Clinical Trial Update: A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting adults with active non-radiographic axial spondyloarthritis to evaluate SHR-1314.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Active Non-radiographic Axial Spondyloarthritis

Drugs mentioned

• SHR-1314 (SHR-1314)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Active Non-radiographic Axial Spondyloarthritis | Phase 3 | Status: RECRUITING